Contact Us | Home
Toll Free No. for USA/Canada:   1-866-279-8368
| Advance Search
 
Currency:  $ £
Discounted Reports
MARKET RESEARCH SECTOR IN FOCUS
Energy & Resources
FMCG & Retailing
Pharmaceuticals and Healthcare
Textiles
MARKET REPORT DETAIL

The 2013-2018 World Outlook for Ophthalmic Pharmaceutical Drugs

Enquire | Email | Print

ISBN: 111488085X
Published Date: Jul, 2013
Format: PDF
No of Pages: 193
 
 
Select pricing :
Change Currency: EURO | $ USD | £ GBP
Buy through us and save. We do not add any Tax / Duty including VAT,GST
  • Abstract
  • Table of Contents

This econometric study covers the world outlook for ophthalmic pharmaceutical drugs across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the 230 countries of the world). This study gives, however, my estimates for the worldwide latent demand, or the P.I.E. for ophthalmic pharmaceutical drugs. It also shows how the P.I.E. is divided across the world’s regional and national markets. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business.

Table Of Contents:

1 INTRODUCTION 11
1.1 Overview 11
1.2 What is Latent Demand and the P.I.E.? 11
1.3 The Methodology 12
1.3.1 Step 1. Product Definition and Data Collection 14
1.3.2 Step 2. Filtering and Smoothing 15
1.3.3 Step 3. Filling in Missing Values 16
1.3.4 Step 4. Varying Parameter, Non-linear Estimation 16
1.3.5 Step 5. Fixed-Parameter Linear Estimation 17
1.3.6 Step 6. Aggregation and Benchmarking 17
1.3.7 Step 7. Latent Demand Density: Allocating Across Cities 17
1.4 Frequently Asked Questions (FAQ) 18
1.4.1 Category Definition 18
1.4.2 Units 18
1.4.3 Methodology 19
2 SUMMARY OF FINDINGS 21
2.1 The Worldwide Market Potential 21
3 AFRICA & THE MIDDLE EAST 23
3.1 Executive Summary 23
3.2 Afghanistan 24
3.3 Algeria 25
3.4 Angola 26
3.5 Armenia 27
3.6 Azerbaijan 28
3.7 Bahrain 28
3.8 Benin 29
3.9 Botswana 30
3.10 Burkina Faso 31
3.11 Burundi 31
3.12 Cameroon 32
3.13 Cape Verde 33
3.14 Central African Republic 33
3.15 Chad 34
3.16 Comoros 35
3.17 Congo (formerly Zaire) 35
3.18 Cote d'Ivoire 36
3.19 Djibouti 37
3.20 Egypt 37
3.21 Equatorial Guinea 38
3.22 Ethiopia 39
3.23 Gabon 40
3.24 Ghana 40
3.25 Guinea 41
3.26 Guinea-Bissau 42
3.27 Iran 42
3.28 Iraq 43
3.29 Israel 44
3.30 Jordan 45
3.31 Kenya 46
3.32 Kuwait 47
3.33 Kyrgyzstan 47
3.34 Lebanon 48
3.35 Lesotho 49
3.36 Liberia 49
3.37 Libya 50
3.38 Madagascar 51
3.39 Malawi 51
3.40 Mali 52
3.41 Mauritania 53
3.42 Mauritius 53
3.43 Morocco 54
3.44 Mozambique 55
3.45 Namibia 55
3.46 Niger 56
3.47 Nigeria 57
3.48 Oman 58
3.49 Pakistan 58
3.50 Palestine 59
3.51 Qatar 60
3.52 Republic of Congo 60
3.53 Rwanda 61
3.54 Sao Tome E Principe 62
3.55 Saudi Arabia 62
3.56 Senegal 63
3.57 Sierra Leone 64
3.58 Somalia 64
3.59 South Africa 65
3.60 Swaziland 66
3.61 Syrian Arab Republic 66
3.62 Tajikistan 67
3.63 Tanzania 68
3.64 The Gambia 68
3.65 The United Arab Emirates 69
3.66 Togo 70
3.67 Tunisia 71
3.68 Turkey 72
3.69 Turkmenistan 73
3.70 Uganda 73
3.71 Uzbekistan 74
3.72 Western Sahara 75
3.73 Yemen 76
3.74 Zambia 76
3.75 Zimbabwe 77
4 ASIA 79
4.1 Executive Summary 79
4.2 Bangladesh 80
4.3 Bhutan 81
4.4 Brunei 82
4.5 Burma 82
4.6 Cambodia 83
4.7 China 84
4.8 Hong Kong 85
4.9 India 85
4.10 Indonesia 86
4.11 Japan 87
4.12 Laos 88
4.13 Macau 89
4.14 Malaysia 90
4.15 Maldives 91
4.16 Mongolia 91
4.17 Nepal 92
4.18 North Korea 93
4.19 Papua New Guinea 94
4.20 Philippines 94
4.21 Seychelles 95
4.22 Singapore 96
4.23 South Korea 96
4.24 Sri Lanka 97
4.25 Taiwan 98
4.26 Thailand 99
4.27 Vietnam 99
5 EUROPE 101
5.1 Executive Summary 101
5.2 Albania 102
5.3 Andorra 103
5.4 Austria 104
5.5 Belarus 105
5.6 Belgium 106
5.7 Bosnia and Herzegovina 107
5.8 Bulgaria 107
5.9 Croatia 108
5.10 Cyprus 109
5.11 Czech Republic 109
5.12 Denmark 110
5.13 Estonia 111
5.14 Finland 112
5.15 France 113
5.16 Georgia 114
5.17 Germany 114
5.18 Greece 115
5.19 Hungary 116
5.20 Iceland 117
5.21 Ireland 118
5.22 Italy 118
5.23 Kazakhstan 119
5.24 Latvia 120
5.25 Liechtenstein 121
5.26 Lithuania 122
5.27 Luxembourg 122
5.28 Malta 123
5.29 Moldova 124
5.30 Monaco 124
5.31 Norway 125
5.32 Poland 126
5.33 Portugal 127
5.34 Romania 128
5.35 Russia 129
5.36 San Marino 130
5.37 Slovakia 130
5.38 Slovenia 131
5.39 Spain 132
5.40 Sweden 133
5.41 Switzerland 134
5.42 The Netherlands 135
5.43 The United Kingdom 136
5.44 Ukraine 137
6 LATIN AMERICA 138
6.1 Executive Summary 138
6.2 Argentina 140
6.3 Belize 141
6.4 Bolivia 141
6.5 Brazil 142
6.6 Chile 143
6.7 Colombia 144
6.8 Costa Rica 145
6.9 Ecuador 146
6.10 El Salvador 147
6.11 French Guiana 147
6.12 Guatemala 148
6.13 Guyana 149
6.14 Honduras 149
6.15 Mexico 150
6.16 Nicaragua 151
6.17 Panama 152
6.18 Paraguay 153
6.19 Peru 154
6.20 Suriname 155
6.21 The Falkland Islands 155
6.22 Uruguay 156
6.23 Venezuela 157
7 NORTH AMERICA & THE CARIBBEAN 158
7.1 Executive Summary 158
7.2 Antigua and Barbuda 159
7.3 Aruba 160
7.4 Barbados 161
7.5 Bermuda 161
7.6 Canada 162
7.7 Cuba 163
7.8 Dominica 164
7.9 Dominican Republic 164
7.10 Greenland 165
7.11 Grenada 166
7.12 Guadeloupe 167
7.13 Haiti 168
7.14 Jamaica 168
7.15 Martinique 169
7.16 Puerto Rico 170
7.17 St. Kitts and Nevis 171
7.18 St. Lucia 171
7.19 St. Vincent and the Grenadines 172
7.20 The Bahamas 173
7.21 The British Virgin Islands 173
7.22 The Cayman Islands 174
7.23 The U.S. Virgin Islands 175
7.24 The United States 175
7.25 Trinidad and Tobago 176
8 OCEANA 177
8.1 Executive Summary 177
8.2 American Samoa 178
8.3 Australia 179
8.4 Christmas Island 180
8.5 Cook Islands 180
8.6 Fiji 181
8.7 French Polynesia 181
8.8 Guam 182
8.9 Kiribati 183
8.10 Marshall Islands 183
8.11 Micronesia Federation 184
8.12 Nauru 184
8.13 New Caledonia 185
8.14 New Zealand 186
8.15 Niue 187
8.16 Norfolk Island 187
8.17 Palau 188
8.18 Solomon Islands 188
8.19 The Northern Mariana Island 189
8.20 Tokelau 189
8.21 Tonga 190
8.22 Tuvalu 191
8.23 Vanuatu 191
8.24 Wallis and Futuna 192
8.25 Western Samoa 192
9 DISCLAIMERS, WARRANTEES, AND USER AGREEMENT PROVISIONS 194
9.1 Disclaimers & Safe Harbor 194
9.2 Icon Group International, Inc. User Agreement Provisions 195

Related Reports:  

 

Custom Research
If above report doesn't have the business information suitable for your business, we can provide custom research that would be lucrative for your business or enhance your profession. We leverage most comprehensive, affordable, high-quality custom research which will match exact topic & specifications of your choice. Please visit Custom Research page to make an enquiry.

 

Top Go to top of the page

product id: 95588, price: INR 48190, Icon Group International, Inc

International Travel Grant for Members of
MANLIBNET (Management Libraries Network)
We accept
Phone: +91.22.27810772, 27810773
E-mail: info@bharatbook.com
Hours: Mon to Sat 8:00 AM to 8:00 PM IST
Call USA/Canada 1-866-279-8368
 
GPlus
About Trust Online